Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Molecular Metabolism, 49, S.
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wer)
-
Elsevier BV
- (wann)
-
2021
- Urheber
-
Novikoff, Aaron
O'Brien, Shannon L.
Bernecker, Miriam
Grandl, Gerald
Kleinert, Maximilian
Knerr, Patrick J.
Stemmer, Kerstin
Klingenspor, Martin
Zeigerer, Anja
DiMarchi, Richard
Tschöp, Matthias H.
Finan, Brian
Calebiro, Davide
Müller, Timo D.
- DOI
-
10.1016/j.molmet.2021.101181
- URN
-
urn:nbn:de:bvb:384-opus4-899960
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Novikoff, Aaron
- O'Brien, Shannon L.
- Bernecker, Miriam
- Grandl, Gerald
- Kleinert, Maximilian
- Knerr, Patrick J.
- Stemmer, Kerstin
- Klingenspor, Martin
- Zeigerer, Anja
- DiMarchi, Richard
- Tschöp, Matthias H.
- Finan, Brian
- Calebiro, Davide
- Müller, Timo D.
- Universität Augsburg
- Elsevier BV
Entstanden
- 2021
Ähnliche Objekte (12)
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Potential implications of long-acting GLP-1 receptor agonists for critically ill